#DXR

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders Daxor Corporation (Nasdaq: DXR) reported a transformative 2025 with FDA 510(k) clearance in August for a next‑generation portable Blood Volume Analyzer, unaudited operating revenue up 45% YoY, year‑end net assets of $45.89M ($9.07/share), and a post‑year $9.0M registered direct offering in January 2026.The operating division narrowed losses to $268,598 in 2025 while investing in R&D, commercialization, and production to scale placements and sales.

1 week ago

#DXR Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

www.stocktitan.net/news/DXR/daxor-corporati...

0 0 0 0

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share Daxor (Nasdaq: DXR) reported fiscal 2025 results with operating revenue up 45% YoY and total net assets of $45,887,266 as of December 31, 2025. Net Asset Value per share rose to $9.07 (a $1.82 increase). The company received FDA 510(k) clearance in August 2025 for a next‑generation portable Blood Volume Analyzer and closed a $9.0 million registered direct offering in January 2026 at $11.75 per share to fund commercialization and expansion.

1 week ago

#DXR Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share

www.stocktitan.net/news/DXR/daxor-corporati...

0 0 0 0

Daxor Corporation Announces $9 Million Registered Direct Offering Daxor (NasdaqCM: DXR) entered a definitive agreement for a registered direct offering of 765,958 shares at $11.75 per share, expected to close on or about January 26, 2026. Gross proceeds are expected to be approximately $9 million before placement agent fees and offering expenses. The company intends to use net proceeds for general corporate purposes, including working capital. Lake Street Capital Markets is the exclusive placement agent. The related Form N-2 registration was declared effective on January 20, 2026. The offering will be made only by prospectus supplement and accompanying prospectus and will be filed with the SEC.

1 month ago

#DXR Daxor Corporation Announces $9 Million Registered Direct Offering

www.stocktitan.net/news/DXR/daxor-corporati...

0 0 0 0

PRISM MarketView

@prismmarketview.bsky.social

3 months ago

Daxor Corporation Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100®

#DXR expands its BVA platform with three new facility adoptions and the rollout of its next-generation BVA analyzer, signaling accelerating demand for precision fluid management.
prismmarketview.com/companies/da...

0 0 0 0

Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer Daxor (Nasdaq: DXR) announced on November 25, 2025 that its Blood Volume Analysis (BVA) platform expanded into three new facilities, combining on-site analyzer deployments with its CLIA-certified ezBVA Lab Service for next-day results. New adoptions include an Upper Midwest integrated health system using ezBVA for high-volume cardiology and heart failure diagnostics, an Ohio academic medical center using ezBVA for outpatient advanced heart failure management, and a Southwest cardiology group practice that onboarded the new on-site BVA analyzer for immediate in-office assessments. Management said the dual on-site plus lab approach is driving accelerating market traction and anticipated continued sales momentum among clinicians focused on precision fluid management.

3 months ago

#DXR Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer

www.stocktitan.net/news/DXR/daxor-fuels-gro...

0 0 0 0

Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall’25 Conference being held at the JW Marriott Austin, from

4 months ago

#DXR Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25

www.stocktitan.net/news/DXR/daxor-s-new-bva...

0 0 0 0

5 months ago

Planefence ICAO: A117F8
Flt: N17MS DARCYAVIATION PSM - DXR
First seen: 2025-10-04 14:37:35 EDT
Min Alt: 7100 ft MSL
Min Dist: 2.41 mi
planefence adsb - adsbexchange - link

0 0 0 0

5 months ago

Planefence ICAO: AC7F1E
Flt: RLI904 RELIANTAIRCHARTER ACK - DXR
First seen: 2025-10-03 15:01:42 EDT
Min Alt: 17200 ft MSL
Min Dist: 0.61 mi
planefence adsb - adsbexchange - link

0 0 0 0

Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA Daxor Corporation (Nasdaq: DXR) unveiled its newly FDA-cleared next-generation Blood Volume Analysis (BVA) analyzer at the Heart Failure Society of America (HFSA) Annual Scientific Meeting. The new system features enhanced ease of use, speed, and over 95% accuracy.Three pivotal studies from leading institutions validated BVA technology's effectiveness: Banner University Medical Center reported zero unplanned hospital admissions for optimally managed patients, Wellstar Health System demonstrated improved LVAD outcomes with increased survival rates and reduced readmissions, and Geisinger Medical Center confirmed BVA's utility in diagnosing Cardiac Amyloidosis.

5 months ago

#DXR Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA

www.stocktitan.net/news/DXR/daxor-unveils-n...

0 0 0 0

3X Faster Blood Testing: Daxor's Revolutionary FDA-Cleared Heart Failure Analyzer Changes Patient Care Daxor's next-generation BVA analyzer delivers 95% accuracy, 50% less blood draw, and triple the speed. FDA-cleared device targets multi-billion dollar fluid management market. Debuts at HFSA 2025.

5 months ago

#DXR Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting

www.stocktitan.net/news/DXR/daxor-corporati...

0 0 0 0

5 months ago

Planefence ICAO: AD8907
Flt: RLI971 RELIANTAIRCHARTER BWI - DXR
First seen: 2025-09-21 15:30:02 EDT
Min Alt: 766 ft AGL
Min Dist: 1.06 nm
Peak Audio: -44 dBFS
Loudness: 1 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

5 months ago

Planefence ICAO: AD8907
Flt: RLI971 RELIANTAIRCHARTER BWI - DXR
First seen: 2025-09-21 15:05:47 EDT
Min Alt: 241 ft AGL
Min Dist: 2.11 nm
Peak Audio: -44 dBFS
Loudness: 1 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

5 months ago

Planefence ICAO: A69CFD
Flt: RLI526 RELIANTAIRCHARTER PHL - DXR
First seen: 2025-09-18 17:13:14 EDT
Min Alt: 38725 ft MSL
Min Dist: 0.24 mi
planefence adsb - adsbexchange - link

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-09-15 02:22:18 EDT
Min Alt: 241 ft AGL
Min Dist: 0.34 nm
Peak Audio: -40 dBFS
Loudness: 3 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-09-15 01:46:54 EDT
Min Alt: 441 ft AGL
Min Dist: 2.3 nm
Peak Audio: -45 dBFS
Loudness: -1 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: A8C43C
Flt: N664MV FMT DXR - BIS
First seen: 2025-09-14 11:19:45 EDT
Min Alt: 17375 ft MSL
Min Dist: 2.22 mi
planefence adsb - adsbexchange - link

0 0 0 0

6 months ago

Planefence ICAO: A8C43C
Flt: N664MV FMT DXR - BIS
First seen: 2025-09-12 11:41:19 EDT
Min Alt: 16175 ft MSL
Min Dist: 1.57 mi
planefence adsb - adsbexchange - link

0 0 0 0

6 months ago

Planefence ICAO: A69BFD
Flt: RLI525 RELIANTAIRCHARTER BHB - DXR
First seen: 2025-09-09 20:27:03 EDT
Min Alt: 366 ft AGL
Min Dist: 0.98 nm
Peak Audio: -46 dBFS
Loudness: -1 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-09-07 18:40:33 EDT
Min Alt: 591 ft AGL
Min Dist: 0.85 nm
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-09-07 17:32:33 EDT
Min Alt: 441 ft AGL
Min Dist: 2.09 nm
Peak Audio: -47 dBFS
Loudness: -2 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

48% of COVID Patients Got Wrong Fluid Treatment: Daxor Study Reveals Major ICU Assessment Gap New study in Journal of Critical Care reveals widespread fluid status misdiagnosis in COVID-19 and sepsis patients. Daxor's BVA technology demonstrates critical need for precise measurement.

6 months ago

#DXR Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care

www.stocktitan.net/news/DXR/daxor-s-blood-v...

1 0 0 0

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter Daxor Corporation (Nasdaq: DXR), the leader in blood volume measurement technology, released a mid-year shareholder update highlighting significant achievements in 2025. The company secured FDA clearance for its new rapid, lightweight Blood Volume Analysis System in August 2025, which is three times faster and more portable than its predecessor BVA-100.Financial highlights include a 73% increase in unaudited revenues for H1 2025 compared to H1 2024, driven by diagnostic kit sales and military contracts. The company's net assets grew to $36.6 million, with NAV increasing to $7.15 per share, up $0.40 from June 2024.Clinical validation strengthened with multiple studies, including research showing 2.61 times better survival in BVA-identified euvolemic heart failure patients. The company expanded market adoption with multiple new facility adoptions across the U.S. in 2025.

6 months ago

#DXR Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

www.stocktitan.net/news/DXR/daxor-corporati...

0 0 0 0

6 months ago

Planefence ICAO: A8C43C
Flt: N664MV FMT DXR - BIS
First seen: 2025-09-01 18:40:08 EDT
Min Alt: 12150 ft MSL
Min Dist: 2.97 mi
planefence adsb - adsbexchange - link

0 0 0 0

6 months ago

Planefence ICAO: AC7F1E
Flt: RLI904 RELIANTAIRCHARTER ACK - DXR
First seen: 2025-09-01 17:43:13 EDT
Min Alt: 1066 ft AGL
Min Dist: 1.86 nm
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: AC7F1E
Flt: RLI904 RELIANTAIRCHARTER ACK - DXR
First seen: 2025-09-01 16:23:47 EDT
Min Alt: 366 ft AGL
Min Dist: 2.01 nm
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-08-27 16:30:14 EDT
Min Alt: 16450 ft MSL
Min Dist: 0.99 mi
planefence adsb - adsbexchange - link

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-08-21 16:08:39 EDT
Min Alt: 741 ft AGL
Min Dist: 0.91 nm
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

6 months ago

Planefence ICAO: A63612
Flt: RLI527 RELIANTAIRCHARTER SIG - DXR
First seen: 2025-08-21 15:28:31 EDT
Min Alt: 491 ft AGL
Min Dist: 2.13 nm
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0